Home » Stocks » Safeguard Scientifics

Safeguard Scientifics, Inc. (SFE)

Stock Price: $6.19 USD 0.05 (0.81%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 128.64M
Revenue (ttm) n/a
Net Income (ttm) -29.11M
Shares Out 20.67M
EPS (ttm) -1.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $6.19
Previous Close $6.14
Change ($) 0.05
Change (%) 0.81%
Day's Open 6.06
Day's Range 6.06 - 6.22
Day's Volume 46,813
52-Week Range 4.43 - 12.79

More Stats

Market Cap 128.64M
Enterprise Value 117.23M
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date n/a
Shares Outstanding 20.67M
Float 19.68M
EPS (basic) -1.41
EPS (diluted) -1.41
FCF / Share -0.66
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 519,830
Short Ratio 7.81
Short % of Float 2.68%
Beta 1.33
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.73
Revenue n/a
Operating Income -9.88M
Net Income -29.11M
Free Cash Flow -13.56M
Net Cash 11.41M
Net Cash / Share 0.55
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -3.68%
ROE -29.18%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$16.00*
Low
16.0
Current: $6.19
High
16.0
Target: 16.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue----------
Operating Income-9.98-16.87-17.13-18.69-17.55-18.97-21.64-19.47-21.17-20.85
Net Income54.56-15.63-88.57-22.26-59.52-5.15-35.53-39.3611126.61
Shares Outstanding20.6420.5420.4320.3420.8720.9821.3620.9720.7620.54
Earnings Per Share2.64-0.76-4.34-1.09-2.85-0.25-1.66-1.884.741.24
EPS Growth--------282.26%-
Dividend Per Share1.00---------
Operating Cash Flow-19.97-26.04-20.81-18.66-17.75-20.19-21.22-16.53-17.73-16.02
Capital Expenditures----0.43-1.86-0.06-0.04-0.07-0.06-0.11
Free Cash Flow-19.97-26.03-20.81-19.09-19.61-20.25-21.26-16.60-17.79-16.13
Cash & Equivalents25.0546.1628.9630.4463.86137178183253237
Total Debt2.3870.1785.8152.5650.9650.5649.9548.9945.6975.92
Net Cash / Debt22.67-24.02-56.84-22.1212.9086.60128134207161
Assets108146176232257318346374407337
Liabilities5.8478.7694.6762.0561.3460.6361.3460.1758.3690.11
Book Value10266.9881.80170196258285314348246
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Safeguard Scientifics, Inc.
Country United States
CEO Robert J. Rosenthal

Stock Information

Ticker Symbol SFE
Stock Exchange New York Stock Exchange
Sector Financial Services
Industry Asset Management
Unique Identifier NYSE: SFE

Description

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa